Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin

Daisaku Masuda; Shizuya Yamashita

doi:10.5551/jat.ED124

Journal of Atherosclerosis and Thrombosis

Online ISSN : 1880-3873
Print ISSN : 1340-3478
ISSN-L : 1340-3478

J-STAGE home
/
Journal of Atherosclerosis and ...
/
Volume 27 (2020) Issue 7
/
Article overview

Editorial

Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin

Daisaku Masuda, Shizuya Yamashita

Author information

JOURNAL OPEN ACCESS

2020 Volume 27 Issue 7 Pages 637-638

DOI https://doi.org/10.5551/jat.ED124

Browse “Advance online publication” version

Details

Article 1st page

Content from these authors

この記事はクリエイティブ・コモンズ [表示 - 非営利 - 継承 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc-sa/4.0/deed.ja

Favorites & Alerts

Add to favorites
Additional info alert
Citation alert
Authentication alert

Corresponding author

Register with J-STAGE for free!